<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2011-15-2-77-83</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-484</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЖУРНАЛ В ЖУРНАЛЕ (АКТУАЛЬНЫЕ ПРОБЛЕМЫ УРОЛОГИИ, ВОПРОСЫ ПЕДИАТРИЧЕСКОЙ НЕФРОЛОГИИ, ГЕРИАТРИЧЕСКОЙ НЕФРОЛОГИИ)</subject></subj-group></article-categories><title-group><article-title>ОПРЕДЕЛЕНИЕ МОЧЕВОЙ ЭКСКРЕЦИИ МОНОЦИТАРНОГО ХЕМОАТТРАКТИВНОГО ПРОТЕИНА-1 ПРИ ПАТОЛОГИИ ПОЧЕК У ДЕТЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>DETERMINATION OF URINARY EXCRETION OF MONOCYTE HAEMOATTRACTIVE PROTEIN-1 IN RENAL DISEASES IN CHILDREN</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>КАЛЬМЕТЬЕВА</surname><given-names>Л. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>KALMETEVA</surname><given-names>L. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иммунологическая лаборатория с отделением клинической иммунологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ХАЙРУЛЛИНА</surname><given-names>р. М.</given-names></name><name name-style="western" xml:lang="en"><surname>HAYRULLINA</surname><given-names>R. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иммунологическая лаборатория с отделением клинической иммунологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Республиканская детская клиническая больница, г. Уфа</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>10</day><month>02</month><year>2011</year></pub-date><volume>15</volume><issue>2</issue><fpage>77</fpage><lpage>83</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; КАЛЬМЕТЬЕВА Л.Р., ХАЙРУЛЛИНА р.М., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">КАЛЬМЕТЬЕВА Л.Р., ХАЙРУЛЛИНА р.М.</copyright-holder><copyright-holder xml:lang="en">KALMETEVA L.R., HAYRULLINA R.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/484">https://journal.nephrolog.ru/jour/article/view/484</self-uri><abstract/><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>гломерулонефриты</kwd><kwd>почечная недостаточность</kwd><kwd>моноцитарный хемоаттрактивный протеин-1</kwd><kwd>маркеры активности</kwd><kwd>дети</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glomerulonephritis</kwd><kwd>renal failure</kwd><kwd>monocyte hemoattraktivny protein-1</kwd><kwd>markers of activity</kwd><kwd>kids</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Чеботарева НВ, Бобкова ИН, Козловская ЛВ. Молекулярные механизмы интерстициального фиброза при прогрессирующих заболеваниях почек. Нефрология и диализ 2006; (1): 26-35</mixed-citation><mixed-citation xml:lang="en">Чеботарева НВ, Бобкова ИН, Козловская ЛВ. Молекулярные механизмы интерстициального фиброза при прогрессирующих заболеваниях почек. Нефрология и диализ 2006; (1): 26-35</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Картамышева НН, Чумакова ОВ, Кучеренко АГ. Некоторые механизмы формирования тубулоинтерстициального компонента при хронических заболеваниях почек. Мед науч и учебно-метод журн 2002; (6): 176-187</mixed-citation><mixed-citation xml:lang="en">Картамышева НН, Чумакова ОВ, Кучеренко АГ. Некоторые механизмы формирования тубулоинтерстициального компонента при хронических заболеваниях почек. Мед науч и учебно-метод журн 2002; (6): 176-187</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">AmikoGD. Tubulointerstitium as predictor of progression of glomerular diseases. Nephron 1999; 83 (4): 289-295</mixed-citation><mixed-citation xml:lang="en">AmikoGD. Tubulointerstitium as predictor of progression of glomerular diseases. Nephron 1999; 83 (4): 289-295</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Border WA, Noble NA. Transforming growth factor-в in tissue fibrosis. N Eng J Med 1994; 331: 1286-1292</mixed-citation><mixed-citation xml:lang="en">Border WA, Noble NA. Transforming growth factor-в in tissue fibrosis. N Eng J Med 1994; 331: 1286-1292</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Viedt C, Orth S. Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? Nephrol Dial Transplant 2002; 17: 2043-2047</mixed-citation><mixed-citation xml:lang="en">Viedt C, Orth S. Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? Nephrol Dial Transplant 2002; 17: 2043-2047</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wada T, Yokoyama H, Su S, Mukaida N, Iwano M et al. Monitoring urinary levels of Monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 1996; 49: 761-767</mixed-citation><mixed-citation xml:lang="en">Wada T, Yokoyama H, Su S, Mukaida N, Iwano M et al. Monitoring urinary levels of Monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 1996; 49: 761-767</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Картамышева НН, Сергеева ТВ, Кучеренко АГ. Моноцитарный хемоаттрактивный протеин-1 (МСР-1) в патогенезе изменений тубулоинтерстициальной ткани у детей с хроническим гломерулонефритом. Нефрология и диализ 2005;(4):443-447</mixed-citation><mixed-citation xml:lang="en">Картамышева НН, Сергеева ТВ, Кучеренко АГ. Моноцитарный хемоаттрактивный протеин-1 (МСР-1) в патогенезе изменений тубулоинтерстициальной ткани у детей с хроническим гломерулонефритом. Нефрология и диализ 2005;(4):443-447</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wada T, Furuichi K, Segawa C, Shimizu M et al. MIP-1б and MCP-1 contribute crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 1999; 56: 995-1003</mixed-citation><mixed-citation xml:lang="en">Wada T, Furuichi K, Segawa C, Shimizu M et al. MIP-1б and MCP-1 contribute crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 1999; 56: 995-1003</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Yokoyama H, Wada T, Furuichi K, Segawa C et al. Urinary levels chemokines (MCAFD MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukocyte Biol 1998; 63: 493-499</mixed-citation><mixed-citation xml:lang="en">Yokoyama H, Wada T, Furuichi K, Segawa C et al. Urinary levels chemokines (MCAFD MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukocyte Biol 1998; 63: 493-499</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tam FWK, Sanders J-S, George A, Hammad T at al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant 2004; 19: 2761-2768</mixed-citation><mixed-citation xml:lang="en">Tam FWK, Sanders J-S, George A, Hammad T at al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant 2004; 19: 2761-2768</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
